Christopher N. Casciano
- Oncology top 5%
- Pharmacology top 2%
- Pediatrics, Perinatology and Child Health top 5%
- Molecular Biology
- Infectious Diseases top 10%
- Co-authors
- Robert P. ClementWilliam W. JohnsonEr‐jia WangEr-jia WangAndrew ParkinsonMitchell N. CayenJames F. LongGlen Tetzloff
- Topics
- Drug Transport and Resistance Mechanisms (11 papers)Pharmacogenetics and Drug Metabolism (6 papers)Pharmacological Effects and Toxicity Studies (4 papers)
- Journals
- Biochemical and Biophysical Research CommunicationsAntimicrobial Agents and ChemotherapyJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Christopher N. Casciano
14 papers receiving 753 citations
Peers
Comparison fields: 5 of 79
- Oncology 477
- Pharmacology 235
- Pediatrics, Perinatology and Child Health 211
- Molecular Biology 187
- Infectious Diseases 152
Countries citing papers authored by Christopher N. Casciano
This map shows the geographic impact of Christopher N. Casciano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher N. Casciano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher N. Casciano more than expected).
Fields of papers citing papers by Christopher N. Casciano
This network shows the impact of papers produced by Christopher N. Casciano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher N. Casciano. The network helps show where Christopher N. Casciano may publish in the future.
Co-authorship network of co-authors of Christopher N. Casciano
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher N. Casciano. A scholar is included among the top collaborators of Christopher N. Casciano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher N. Casciano. Christopher N. Casciano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 187 | |
| 2 | 58 | |
| 3 | 70 | |
| 4 | 148 | |
| 5 | In vitro characterization of the inhibition profile of loratadine, desloratadine, and 3-OH-desloratadine for five human cytochrome P-450 enzymes. | 39 |
| 6 | 35 | |
| 7 | Mechanism-based inactivation of CYP2D6 by 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine. | 20 |
| 8 | 53 | |
| 9 | 27 | |
| 10 | 47 | |
| 11 | 80 | |
| 12 | Design and conduct of studies to meet residue chemistry requirements: residue depletion and metabolism of flunixin in cattle | 1 |
| 13 | 25 | |
| 14 | 20 |
About Christopher N. Casciano
Christopher N. Casciano is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health, having authored 14 papers that have together received 810 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (11 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). The work is most often cited by research in Pharmacology (235 citations), Oncology (477 citations) and Pediatrics, Perinatology and Child Health (211 citations). Christopher N. Casciano has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Robert P. Clement, William W. Johnson, Er‐jia Wang, Er-jia Wang, Andrew Parkinson, Mitchell N. Cayen, James F. Long, Glen Tetzloff, Peter Chiu and A Barnett. Their work appears in journals such as Biochemical and Biophysical Research Communications, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.